Sign Up Today and Learn More About Headway Stock
Invest in or calculate the value of your shares in Headway or other pre-IPO companies through EquityZen's platform.
Headway Stock (HEAW)
Headway is a mental healthcare system provider that helps patients connect with therapists and submit insurance claims online.
About Headway Stock
Founded
2019
Headquarters
New York, NY, US
Industries
Content and Publishing, Messaging and Telecommunications, Advertising
Headway is a mental healthcare system provider based in New York. It develops a health insurance advisory platform designed to connect patients with therapists and provides administrative support to therapists who don’t typically accept insurance. The company was founded by Andrew Adams, Jake Sussman, Dan Ross, and Kevin Chan in 2019.
Headway Press Mentions
Stay in the know about the latest news on Headway
The Secret is Out: This is How So Many Business Owners Keep Learning New Skills Headway makes it so even busy entrepreneurs can fit growth in their schedule.
entrepreneur • May 05, 2025
Summarise all the best books with Headway Premium for just £45
mashable • Apr 24, 2025
These 4 Growing Companies Offer Tech Talent the Chance to Leave Their Mark
builtinnyc • Apr 04, 2025
Headway is your shortcut to success — and just £37 for life
mashable • Mar 27, 2025
Let’s run away together: I’m a therapist leaving venture capital-backed mental health.
medium • Mar 27, 2025
Investors in Headway
Discover investors in Headway stock and explore their portfolio companies
Headway Management
Leadership team at Headway
CEO
Andrew Adams
Co-Founder
Kevin Chan
Join now and verify your accreditation status to gain access to:
- Headway Current Valuation
- Headway Stock Price
- Headway Management
- Available deals in Headway and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Headway Cap Table and Funding History by Share Class and Liquidity Preferences
- Headway Revenue and Financials
- Headway Highlights
- Headway Business Model
- Headway Risk Factors
- Headway Research Report from SACRA Research
Trading Headway Stock
How to invest in Headway stock?
Accredited investors can buy pre-IPO stock in companies like Headway through EquityZen funds. These investments are made available by existing Headway shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Headway stock?
Shareholders can sell their Headway stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
